🇺🇸 INTERFERON ALFACON-1 in United States

242 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 40 reports (16.53%)
  2. Headache — 31 reports (12.81%)
  3. Pyrexia — 27 reports (11.16%)
  4. Weight Decreased — 25 reports (10.33%)
  5. White Blood Cell Count Decreased — 23 reports (9.5%)
  6. Asthenia — 20 reports (8.26%)
  7. Depression — 20 reports (8.26%)
  8. Nausea — 20 reports (8.26%)
  9. Haemoglobin Decreased — 18 reports (7.44%)
  10. Platelet Count Decreased — 18 reports (7.44%)

Source database →

INTERFERON ALFACON-1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is INTERFERON ALFACON-1 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for INTERFERON ALFACON-1 in United States?

Marketing authorisation holder not available in our data.